73 Million Americans May Buy CBD by the End of 2020

Share on facebook
Share on twitter
Share on linkedin
Share on reddit
Share on whatsapp
Share on pinterest

The Hemp Business Journal, the cannabis division of New Frontier Data, a global authority on cannabis industry data, analysis, and business intelligence, released the US Hemp Market Report: Cannabinoids Edition, Volume 1, New Frontier Data’s before the Hemp Cannabinoid Webinar Series The first in a multi-set hemp webinar series. The series and report, in collaboration with US-based medical-grade cannabis ingredient manufacturer Groff North America and the integrated cannabis health care system Farmacy Health, outlined the significant developments in the North American cannabis market.

“Given that more than 3 in 5 Americans believe CBD has valid medical uses, the potential wellness value hemp may provide can no longer go unnoticed,” said New Frontier Data Founder and CEO Giadha A. DeCarcer. “New Frontier Data’s research and analysis indicate the market value of cannabinoids will continue to grow as consumers’ access increases, and the therapeutic value of minor cannabinoids such as CBN and CBG are better understood.”


The Hemp Cannabinoid Webinar Series episodes’ topics include:

  • Episode 1: “Risks & Opportunities in the Hemp-Cannabinoid Market”
  • Episode 2: “The Future of Minor Cannabinoids Beyond CBD”
  • Episode 3: “Innovation in CBD Food & Beverage”

Hemp Cannabinoid Series FREE REGISTRATION: https://zoom.us/webinar/register/WN_KI1E54B2RPKpyj85Rga3cQ

U.S. Hemp Market Report: Cannabinoids Edition, Volume 1, FREE DOWNLOAD: https://newfrontierdata.com/product/us-hemp-market-report-cannabinoids-edition-volume-1/

For speeches and sponsorship opportunities, please contact Sponsor@NewFrontierData.com.

Drug War丨Healthline
Drug War丨Healthline

About the new boundary data:

New Frontier Data is an independent, technology-driven analysis company specializing in the global cannabis industry. It provides investors, operators, researchers, and policymakers with censored data, actionable business intelligence, and risk management solutions. New Frontier Data reports and data have been cited in more than 80 countries around the world to inform industry leaders. New Frontier Data was founded in 2014 and headquartered in Washington, DC, with other offices in Denver, Colorado, and London, England.

New Frontier Data has no position on the advantages and disadvantages of cannabis legalization. Instead, its mission and tasks are to provide information for marijuana-related policies and business decisions through a strict, irrelevant, and comprehensive analysis of the global legal cannabis industry. For more information about the new boundary data, please visit https://www.NewFrontierData.com.

Farmacy Health

Farmacy Health is a comprehensive health system built around the science and application of cannabis as a medicine. Our organization led by experienced doctors and leading researchers committed to the development of medicine, treatment, and community health through the use of cannabis and its ingredients.

Groff North America

Groff NA Hemplex is a physician-owned cannabis company dedicated to the cultivation, processing, and packaging of medical-grade cannabis. We process and refine the beneficial compounds and materials of hemp to benefit humanity and the planet further. Hemplex specializes in customized science-based cannabinoid formulations to meet consumer and market needs. We will continue to develop innovative and proven products for our customers through the combination of technology and human capital.

This article is issued by New Frontier Data.

© 2019-2020 VAPEBIZ.NET All Rights Reserved. Content Can Not Be Translated or Reproduced without Authorization.

Related Articles

0 0 vote
Article Rating
Notify of
Your Name
Your Email
Inline Feedbacks
View all comments